New drug candidates and therapeutic targets for tuberculosis therapy

This publication has 70 references indexed in Scilit:

• Prokaryotic toxin–antitoxin stress response loci
  Nature Reviews Microbiology, 2005
• Simultaneous estimation of pharmacokinetic properties in mice of three anti-tubercular ethambutol analogs obtained from combinatorial lead optimization
  Journal of Pharmaceutical and Biomedical Analysis, 2005
• New TB Drug Promises Shorter, Simpler Treatment
  Science, 2004
• Systems biology in drug discovery
  Nature Biotechnology, 2004
• The search for new sterilizing anti-tuberculosis drugs
  Frontiers in Bioscience-Landmark, 2004
• Combinatorial Lead Optimization of [1,2]-Diamines Based on Ethambutol as Potential Antituberculosis Preclinical Candidates
  Journal of Combinatorial Chemistry, 2003
• Demonstration that fbiC Is Required by Mycobacterium bovis BCG for Coenzyme F ₄₂₀ and FO Biosynthesis
  Journal of Bacteriology, 2002
• Durable Cure for Tuberculosis: Rifalazil in Combination with Isoniazid in a Murine Model of Mycobacterium tuberculosis Infection
  Clinical Infectious Diseases, 2000
• Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
  Nature, 1998
• Oxazolidinones, a new class of synthetic antituberculosis agent in vitro and in vivo activities of DuP-721 against Mycobacterium tuberculosis
  Diagnostic Microbiology and Infectious Disease, 1991